Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 138.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.00
  • 52 Week Low: 102.50
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 10,761
  • Market Cap: £146.60m
  • RiskGrade: 135

Cello Group fails to strike a chord despite strong results

Date: Thursday 19 Mar 2015

LONDON (ShareCast) - Results from marketing group Cello Group hit a bum note with investors despite pleasing profits growth, a healthy hike in the dividend and a solid start made to 2015.
Shares in the AIM-listed company fell despite chief executive Mark Scott hailing the improvement in fortunes as Cello became established as a "global player" in the pharmaceutical space, as it was the first full year of trading under the unified Cello Health brand.

Revenue rose 6.4% to £169.9m in 2014, with gross profit up 8.4% to £81m and headline profit before tax up 9.9% to £9.4m.

Headline basic earnings per share climbed 12.3% to 8.14p and despite operating cash flow more than halving to £4.8m - reflecting excessive cash conversion the year before - the dividend was lifted 15.6% to 2.6p.

Scott said the new unified operating structure had a strong positive impact on the ability to compete for and win large integrated contracts on a global scale, which underpinned Cello's ability to continue its rapid expansion in the core US market.

"The new year has started well, with good income visibility and solid momentum from the end of 2014," he added.

Broker N+1 Singer noted that the HMRC VAT review of the charity clients of Cello Signal, the non-health business, looked to be better than analysts had assumed, with a lower cash cost, and the business was now trading normally after some disruption.

"The trading outlook is bright and Cello is continuing to progress the development of both units, Health through a planned expansion of consultancy activity and Signal through better solutions."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 138.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.00
52 Week Low 102.50
Volume 10,761
Shares Issued 106.23m
Market Cap £146.60m
RiskGrade 135

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.06% below the market average58.06% below the market average58.06% below the market average58.06% below the market average58.06% below the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Price Trend
58.37% above the market average58.37% above the market average58.37% above the market average58.37% above the market average58.37% above the market average
35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average
Income
21.01% above the market average21.01% above the market average21.01% above the market average21.01% above the market average21.01% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average
47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average47.06% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 21-Jan-2020

Time Volume / Share Price
11:44 84,025 @ 138.00p
11:44 85,000 @ 138.00p
16:09 30 @ 138.00p
12:13 7,000 @ 139.00p
08:40 1,000 @ 139.90p

Cello Health Key Personnel

CEO Mark Scott

Top of Page